Log in to save to my catalogue

Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders

Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4102824

Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders

About this item

Full title

Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders

Publisher

Cham: Springer International Publishing

Journal title

Paediatric drugs, 2014-08, Vol.16 (4), p.275-291

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Childhood neurotransmitter disorders are increasingly recognised as an expanding group of inherited neurometabolic syndromes. They are caused by disturbance in synthesis, metabolism, and homeostasis of the monoamine neurotransmitters, including the catecholamines (dopamine, norepinephrine, and epinephrine) and serotonin. Disturbances in monoamine n...

Alternative Titles

Full title

Clinical Features and Pharmacotherapy of Childhood Monoamine Neurotransmitter Disorders

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4102824

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4102824

Other Identifiers

ISSN

1174-5878

E-ISSN

1179-2019

DOI

10.1007/s40272-014-0079-z

How to access this item